LOGIN
75 mg risedronate once-monthly appears well tolerated in Japanese osteoporosis patients
April 2015
75 mg risedronate once-monthly appears well tolerated in Japanese osteoporosis patients
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Efficacy, tolerability and safety of once-monthly administration of 75 mg risedronate in Japanese patients with involutional osteoporosis: A comparison with a 2.5 mg once-daily dosage regimen
Bone. 2014 Feb;59:44-52. doi: 10.1016/j.bone.2013.10.017. Epub 2013 Oct 29.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
852 Japanese patients with involutional osteoporosis were randomized to receive 75 mg oral risedronate once-monthly or 2.5 mg oral risedronate once-daily, with the purpose of comparing the efficacy, tolerability, and safety of both treatment options. Upon analysis, results indicated that 75 mg risedronate tablets taken once a month achieved similar bone mineral density and fracture rates compared ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.